The Leadership Team at Neurotez Inc. drives strategic direction and oversees the development of Leptin hormone replacement therapy for Alzheimer's disease. Composed of top executives, including the CEO and CFO, they collaborate on critical decision-making, ensure operational efficiency, and guide cross-functional initiatives to advance the company's mission. Their collective expertise supports innovation and regulatory compliance, ultimately aiming to improve patient outcomes in neurodegenerative disorders.
View all